http://www.movac.co.nz/Movac Angel Investment Blogen-usWed, 10 Mar 2010 15:43:16 GMTWed, 10 Mar 2010 15:43:16 GMThttp://www.movac.co.nz/rssConneXions 2.1phil@movac.co.nz (Phil)phil@movac.co.nz (Phil)http://www.movac.co.nz/blog/OnYa-Kiwi-Entrepreneurs-32336.htm 2010 has got off to a great start! The quality that we're seeing in the opportunities being put in front of us is the best it's ever been. So good on you, Kiwi Entrepreneurs and their backers. Typically what we're seeing at the moment are: Businesses that are up and running. Initial product development is done, market entry is mapped out and the core team is in place. Tue, 2 Mar 2010 07:05:30 GMThttp://www.movac.co.nz/blog/item-32336http://www.movac.co.nz/blog/Mesynthes-Obtains-U.S.-FDA-510(k)-Clearance-for--Endoform-Dermal-Template™-32311.htmNovel Biomaterial for Wound Healing and Regenerative Medicine WELLINGTON, NZ (February 2, 2010): Mesynthes, a privately held regenerative medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Endoform Dermal TemplateTM. Endoform, a proprietary extracellular matrix biomaterial, provides a unique biologic template for tissue regeneration. Tue, 2 Feb 2010 21:41:17 GMThttp://www.movac.co.nz/blog/item-32311